Arkolith/Insider Trading/KDNY/Form 4

Bjerkholt Eric

Chief Financial OfficerCHINOOK THERAPEUTICS, INC. (KDNY) · full profile →Form 4 · filed Aug 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
1 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Disposed to issuer(D)39K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2023Disposed to issuer(D)84K$14.73$1.2M0
Aug 11, 2023Disposed to issuer(D)88K$27.10$2.4M0
Aug 11, 2023Disposed to issuer(D)22K$24.86$535K0
Aug 11, 2023Disposed to issuer(D)145K$26.02$3.8M0
Aug 11, 2023Disposed to issuer(D)16K——0
Aug 11, 2023Disposed to issuer(D)8K——0
Aug 11, 2023Disposed to issuer(D)21K——0
Aug 11, 2023Disposed to issuer(D)15K——0
Aug 11, 2023Disposed to issuer(D)2K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-045414) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML